ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bodnar, E.
Right arrow Articles by Ross, D. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bodnar, E.
Right arrow Articles by Ross, D. N.

The Annals of Thoracic Surgery, Vol 47, 799-805, Copyright © 1989 by The Society of Thoracic Surgeons


ARTICLES

Viable and nonviable aortic homografts in the subcoronary position: a comparative study

E Bodnar, O Matsuki, R Parker and DN Ross
Cardiothoracic Institute, National Heart Hospital, London, England.

One hundred fifty-five freeze-dried, 63 frozen, and 337 Hanks'- antibiotic solution preserved or nutrient-antibiotic solution preserved homografts used for isolated aortic valve replacement have been followed for 1 to 20 years (mean, 5.3 years), a total of 2,931 patient- years of follow-up information. Overall survival, valve-related death, primary tissue failure, failure due to surgical technical error, infective endocarditis, and overall event-free survival have been assessed and compared. Overall survival 20 years after operation was 51.6% +/- 8.1% with a low incidence of sudden death. The method and length of preservation did not have any effect on the long-term performance or the mode of failure of the homografts. The rate of primary tissue failure was apparently higher with valves preserved in a solution containing calf serum, but the difference was not significant. It is concluded that long-term patient survival and quality of life after aortic valve replacement with a homograft are excellent. The current study, however, could not verify the existence of a significant difference between the three assessed methods of homograft preservation. Furthermore, it could not prove the importance of cellular viability or the existence of clinically significant immunological factors other than the calf serum content of the nutrient medium.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
T. Athanasiou, C. Jones, R. Jin, G. L. Grunkemeier, and D. N. Ross
Homograft Implantation Techniques in the Aortic Position: To Preserve or Replace the Aortic Root?
Ann. Thorac. Surg., May 1, 2006; 81(5): 1578 - 1585.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Aagaard and P. V. Andersen
Acute endocarditis treated with radical debridement and implantation of mechanical or stented bioprosthetic devices
Ann. Thorac. Surg., January 1, 2001; 71(1): 100 - 103.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Homann, J. C. Haehnel, N. Mendler, S. U. Paek, K. Holper, H. Meisner, and R. Lange
Reconstruction of the RVOT with valved biological conduits: 25 years experience with allografts and xenografts
Eur. J. Cardiothorac. Surg., June 1, 2000; 17(6): 624 - 630.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
P. Biberthaler, N. Mendler, U. Ettner, and H. Meisner
Endothelial prostacyclin (PGI-2) production of human and porcine valve allografts related to ischemic history
Eur. J. Cardiothorac. Surg., November 1, 1999; 14(5): 503 - 507.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. Hahn, S. K.C. Tam, G. J. Vlahakes, A. D. Hilgenberg, C. W. Akins, and M. J. Buckley
Repeat aortic root replacement
Ann. Thorac. Surg., July 1, 1998; 66(1): 88 - 91.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. C. Song, L. Y. Yao, J. M. Kneebone, and F. M. Lupinetti
EFFECT OF CRYOPRESERVATION AND HISTOCOMPATIBILITY ON TYPE I PROCOLLAGEN GENE EXPRESSION IN AORTIC VALVE GRAFTS
J. Thorac. Cardiovasc. Surg., September 1, 1997; 114(3): 421 - 427.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
R. C. Elkins, M. M. Lane, and C. McCue
Pulmonary Autograft Reoperation: Incidence and Management
Ann. Thorac. Surg., August 1, 1996; 62(2): 450 - 455.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
X. J. Feng, C. E. J. Van Hove, P. J. Walter, and A. G. Herman
EFFECTS OF STORAGE TEMPERATURE AND FETAL CALF SERUM ON THE ENDOTHELIUM OF PORCINE AORTIC VALVES
J. Thorac. Cardiovasc. Surg., January 1, 1996; 111(1): 218 - 230.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. G. Hazekamp, D. R. Koolbergen, J. Braun, H. Sugihara, C. J. Cornelisse, Y. A. Goffin, and H. A. Huysmans
In situ hybridization: A new technique to determine the origin of fibroblasts in cryopreserved aortic homograft valve explants
J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 248 - 257.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1989 by The Society of Thoracic Surgeons.